---
schema_version: "secwatch.filing_event.v1"
accession: "0000950142-22-002215"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2022-07-15T23:59:59+00:00"
generated_at: "2026-06-24T14:08:22.272047+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics appoints Dr. Keith Harris and Dr. Fahed Al Marzooqi to board

## Summary
- Dr. Keith Harris appointed as Board member and chair of Audit Committee; Dr. Fahed Al Marzooqi appointed as Board member.
- Dr. Harris is a London-based investment banker with 30-year career at Morgan Grenfell, Drexel Burnham, Apax, and HSBC.
- Dr. Al Marzooqi is COO of G42 Healthcare; his appointment follows the May 2022 stock purchase agreement with G42 Investments.
- Each new director receives $35k annual cash, 25,000 options upon appointment, plus 25,000 options in annual equity grants.
- Dr. Harris qualifies as independent and as an audit committee financial expert under SEC rules.

## SEC filing metadata
- accession: 0000950142-22-002215
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2022-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000095014222002215/0000950142-22-002215-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000095014222002215/eh220270165_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950142-22-002215
- JSON: https://secwatch.observer/filing/0000950142-22-002215.json
- Plain text: https://secwatch.observer/filing/0000950142-22-002215.txt

## Key facts
- Executive change
  Dr. Keith Harris was appointed as member of the Board and a member and chair of the Audit Committee of the Board at vTv Therapeutics Inc..
  - Action: appointed
  - Role: member of the Board and a member and chair of the Audit Committee of the Board
  source text: appointed (i) Dr. Keith Harris as a member of the Board and a member and chair of the Audit Committee of the Board, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000095014222002215/0000950142-22-002215-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.